Invention Application
- Patent Title: Pyridinone and Pyridazinone Derivatives
- Patent Title (中): 吡啶酮和哒嗪酮衍生物
-
Application No.: US13796437Application Date: 2013-03-12
-
Publication No.: US20130331382A1Publication Date: 2013-12-12
- Inventor: Robert D. HUBBARD , Le WANG , Chang H. PARK , Chaohong SUN , Keith F. McDANIEL , John K. PRATT , Todd N. SOLTWEDEL , Michael D. WENDT , John H. HOLMS , Dachun LIU , George S. SHEPPARD
- Applicant: ABBVIE INC.
- Priority: CNPCT/CN2012/076748 20120612
- Main IPC: A61K31/541
- IPC: A61K31/541 ; A61K31/50 ; A61K45/06 ; C07D213/64 ; A61K31/4412 ; A61K31/5377 ; A61K31/501 ; C07D403/04 ; C07D401/10 ; C07D403/10 ; C07D417/10 ; C07D413/10 ; C07D237/14 ; C07D401/04
Abstract:
The present invention provides for compounds of formula (I) wherein A1, A2, A3, A4, J, and X3 have any of the values defined therefor in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, diabetes, obesity, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula I.
Public/Granted literature
- US09561231B2 Pyridinone and pyridazinone derivatives Public/Granted day:2017-02-07
Information query
